Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy
- PMID: 34593538
- PMCID: PMC8576503
- DOI: 10.2337/dbi21-0030
Annexin 1 Mimetic Ac2-26 Holds Promise for the Treatment of Diabetic Nephropathy
Comment on
-
The Attenuation of Diabetic Nephropathy by Annexin A1 via Regulation of Lipid Metabolism Through the AMPK/PPARα/CPT1b Pathway.Diabetes. 2021 Oct;70(10):2192-2203. doi: 10.2337/db21-0050. Epub 2021 Jun 8. Diabetes. 2021. PMID: 34103347
References
-
- Wu L, Liu C, Chang D-Y, et al. . The attenuation of diabetic nephropathy by annexin A1 via regulation of lipid metabolism through the AMPK/PPARα/CPT1b pathway. Diabetes 2021;70:2192–2203 - PubMed
-
- McKanna JA, Cohen S. The EGF receptor kinase substrate p35 in the floor plate of the embryonic rat CNS. Science 1989;243:1477–1479 - PubMed
-
- Gerke V, Creutz CE, Moss SE. Annexins: linking Ca2+ signalling to membrane dynamics. Nat Rev Mol Cell Biol 2005;6:449–461 - PubMed
-
- Perretti M, D’Acquisto F. Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat Rev Immunol 2009;9:62–70 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
